NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.90 +0.05 (+1.85%)
As of: Oct 2, 2026 · 2:56 PM EDT

NRX Pharmaceuticals (NRXP) Return on Assets [ROA] (2018 - 2026)

Updated

NRX Pharmaceuticals (NRXP) reported Return on Assets [ROA] of -91.27% for Q2 2026, up 118.17 percentage points from -209.45% a year earlier and up 53.63 percentage points from the prior quarter.

Analysis

NRX Pharmaceuticals (NRXP) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For FY2025, NRX Pharmaceuticals posted Return on Assets [ROA] of -203.32%, up 137.51 percentage points from FY2024.

  • Return on Assets [ROA] has a five-year change of +92.51 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at -340.84% in FY2024 (-175.05 pp), -165.78% in FY2023 (-29.98 pp), -135.81% in FY2022 (+385.99 pp) and -521.80% in FY2021 (-225.96 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Assets [ROA] since Q3 2020.
  • Year over year, Return on Assets [ROA] has now increased in each of the last six quarters, with an average year-over-year change of +104.94 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q4 2021 (a gain of 935.71 percentage points); the low point was Q2 2024 (a drop of 369.09 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -144.91% (Q1 2026), -120.81% (Q4 2025) and -141.38% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 NRX Pharmaceuticals 126.02 Mn 77.61 Mn 426,000.00 -91.27%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -91.27%
Mar 31, 2026 -144.91%
Dec 31, 2025 -120.81%
Sep 30, 2025 -141.38%
Jun 30, 2025 -209.45%
Mar 31, 2025 -290.54%
Dec 31, 2024 -460.69%
Sep 30, 2024 -425.09%
Jun 30, 2024 -516.68%
Mar 31, 2024 -439.25%
Dec 31, 2023 -215.69%
Sep 30, 2023 -166.31%
Jun 30, 2023 -147.59%
Mar 31, 2023 -135.41%
Dec 31, 2022 -174.13%
Sep 30, 2022 -226.13%
Jun 30, 2022 -243.95%
Mar 31, 2022 -218.22%
Dec 31, 2021 -175.60%
Sep 30, 2021 -260.77%
API Access

NRX Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NRXP&period=max&api_key=YOUR_API_KEY